The chikungunya virus virus-like particle vaccine is well tolerated and shows high immunogenicity in both previous recipients of alphavirus vaccines and alphavirus vaccine–naive control individuals.

However, VLP systems have their own limitations, such as susceptibility to signal blockages and the impact of the receiver's changing inclination, which can degrade accuracy.

The formation of VLP is depicted in Figure 1. Figure 1. The formation of a virus-like particle (VLP). Image Credit: Sino Biological Inc. To enable targeted drug research, Sino Biological has ...